Digitisation | December 17, 2023
Cipla to further invest Rs. 42 crore in GoApptiv
Expands patient reach to remotest towns by furthering investment in GoApptiv
Expands patient reach to remotest towns by furthering investment in GoApptiv
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
Both the India and GCC entities will be operated by separate dedicated management teams
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
Laurus Labs concluded the acquisition by securing the remaining 8,333 equity shares from the promoter group shareholders
Lack of technology transfer stands out as a formidable barrier
Advances Amgen's mission to serve patients with rare disease medicines
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
New Board of Directors and management team at Suven Pharma also appointed
Subscribe To Our Newsletter & Stay Updated
